![](/wp-content/uploads/2024/01/Screenshot-2024-01-22-at-9.09.51-AM.png)
$599
Dexcom to Build EU Manufacturing Plant; FDA Finds Manufacturing Lapses at Lilly Plant
Two cardiometabolic-related news items have been observed: Dexcom announced its first manufacturing facility in the EU for CGM sensors (view press release); and FDA has reportedly uncovered new manufacturing problems at a Lilly plant (view article). Below, FENIX provides highlights and insights for the respective news items.